NCT03339752View on ClinicalTrials.gov

A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-541468 Can Affect the Fate in the Body (Amount and Time of Presence in the Blood) of Rosuvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 30, 2017

Primary Completion Date

December 2, 2017

Study Completion Date

December 2, 2017

Conditions
Healthy Subjects
Interventions
DRUG

Rosuvastatin

10 mg tablet

DRUG

ACT-541468

25 mg hard capsule

Trial Locations (1)

32300

Cepha s.r.o., Pilsen

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY

NCT03339752 - A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-541468 Can Affect the Fate in the Body (Amount and Time of Presence in the Blood) of Rosuvastatin | Biotech Hunter | Biotech Hunter